Strome Group, Inc., 10% Owner at Zivo Bioscience, Inc. (ZIVO), bought 366,286 shares at $4.99 ($2.8M) on 2021-06-02, disclosed to the SEC on 2023-10-30.
Open-market purchase of $2.8M ZIVO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 40,000 | $200K | 7.1% |
| 2 | $8.00 | 326,286 | $2.6M | 92.9% |
| Total | $7.67 avg | 366,286 | $2.8M | 100% |